Skip to main content
Fig. 6 | BMC Endocrine Disorders

Fig. 6

From: The effects of SGLT2 inhibitors on metabolic phenotype and FGF-21 expression from the adipose tissue and the liver are less pronounced in ob/ob mice

Fig. 6

FGF-21 receptors expression analysis following dapagliflozin administration in lean and ob/ob mice. FGF-R1, FGF-R2, FGF-R4 and β-klotho gene expression was evaluated in the subcutaneous adipose tissue (A and A’), visceral adipose tissue (B and B’), brown adipose tissue (C and C’), and the liver (D and D’) in both lean and ob/ob. Data were expressed as fold change. *p > 0.05

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us